Acura Pharmaceuticals reported 523K in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acelrx Pharmaceuticals ACRX:US $ 8.64M 54K
Acura Pharmaceuticals ACUR:US 523K 138K
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
Johnson & Johnson JNJ:US $ 6B 73M
Nektar Therapeutics NKTR:US $ 29.47M 87K
Pfizer PFE:US $ 2.73B 61M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Shionogi 4507:JP 22.5B 748M
Sun Pharmaceuticals SUNP:IN 18.06B 475.3M
Teva Pharmaceutical TEVA:IT 864M 32M
Xeris Pharmaceuticals Inc XERS:US $ 24.24M 1.69M
Zogenix ZGNX:US $ 39.56M 5.68M